1/1
Supplementary Tables – Attitudes towards pharmacogenetics in patients undergoing CYP2C19 testing following percutaneous coronary intervention
dataset
posted on 2022-01-11, 14:36 authored by Figshare Future Science GroupFigshare Future Science Group, Grace Lee, Lisa A. Varughese, Laura Conway, Carol Stojinski, Sandhya Ashokkumar, Karen Monono, William Matthai, Daniel M. Kolansky, Jay Giri, Sony TutejaSupplemental Table 1: Average Participant Responses to Questions Assessing Attitudes Toward PGx Testing on a Scale of 1 (Strongly Disagree) to 5 (Strongly Agree)
Supplemental Table 2: Average Participant Responses to Questions Assessing Ethics of PGx Testing on a Scale of 1 (Strongly Disagree) to 5 (Strongly Agree)
